The DOI matches its Crossref record.
Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nitrite metabolism can be activated by hypoxia, low pH and reactions with metalloproteins[50–58].”
From Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health (2017) · cites this paper as [50]
Citations
Cited by
Sorted by citations
Items 401–500 of 999
Niwa, K., Lindauer, U., Villringer, A., et al. (1993) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1993.70 · Cited by 67
Bauer, P. M., Buga, G. M., & Ignarro, L. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211443198 · Cited by 67
Self-citationIgnarro, L. J., Gold, M. E., Buga, G. M., Byrns, R. E., Wood, K. S., Chaudhuri, G., & Frank, G. D. (1989) · Circulation Research · doi:10.1161/01.res.64.2.315 · Cited by 67
Self-citationEndothelium-derived relaxing factor in brain blood vessels is not nitric oxide.
Rosenblum, W. I. (1992) · Stroke · doi:10.1161/01.str.23.10.1527 · Cited by 67
“18 Moreover, a thiol intermediate has been strongly implicated in the action of nitrosovasodilators like nitroglycerin.(20) Nevertheless, the overwhelming impression given by article titles, texts, and the name used for the enzyme synthesizing a g cyclase-activating factor(37) is that EDRFACh is NO.”
BackgroundWatanabe, H., Kakihana, M., Ohtsuka, S., Enomoto, T., Yasui, K., & Sugishita, Y. (1993) · Circulation · doi:10.1161/01.cir.88.1.29 · Cited by 65
Gobert, A. P., Semballa, S., Daulouède, S., Lesthelle, S., Taxile, M., Veyret, B., & Vincendeau, P. (1998) · Infection and Immunity · doi:10.1128/iai.66.9.4068-4072.1998 · Cited by 68
“Endothelium-derived relaxing-factor activities (19, 25, 34), inhibition of platelet functions (51), apoptosis (33), and anti-parasite activities of NO (36) are mediated through nitrosylated albumin.”
BackgroundReductive metabolism of nitroprusside in rat hepatocytes and human erythrocytes
Rao, D. N. R., Elguindi, S., & O'Brien, P. J. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90005-4 · Cited by 67
Li, H., Cui, H., Liu, X., & Zweier, J. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411905200 · Cited by 64
Pearson, P. J., Évora, P. R. B., Ayrancioğlu, K., et al. (1992) · Circulation · doi:10.1161/01.cir.86.1.289 · Cited by 65
Moynihan, H. A., & Roberts, S. M. (1994) · Journal of the Chemical Society Perkin Transactions 1 · doi:10.1039/p19940000797 · Cited by 67
Tamaoki, J., Kondo, M., Kohri, K., Aoshiba, K., Tagaya, E., & Nagai, A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2909 · Cited by 65
Hothersall, J. S., Cunha, F. Q., Neild, G. H., & Noronha-Dutra, A. A. (1997) · Biochemical Journal · doi:10.1042/bj3220477 · Cited by 64
Nitric oxide in respiratory diseases
Nevin, B. J., & Broadley, K. J. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00262-0 · Cited by 64
Effect of chronic N-acetylcysteine treatment on the development of spontaneous hypertension
Pecháňová, O., Zicha, J., Vranková, S., Dobešová, Z., Jendeková, L., & Kuneš, J. (2006) · Clinical Science · doi:10.1042/cs20050227 · Cited by 64
Ewing, J. F., & Janero, D. R. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00083-5 · Cited by 64
Henry, P. J., Drummer, O. H., & Horowitz, J. D. (1989) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1989.tb14603.x · Cited by 64
What causes tolerance to nitroglycerin?: The 100 year old mystery continues
Packer, M. (1990) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)80343-2 · Cited by 64
Nitrates and endothelial prostacyclin production: studies in vitro.
Caterina, R. D., Dorso, C. R., Tack-Goldman, K., et al. (1985) · Circulation · doi:10.1161/01.cir.71.1.176 · Cited by 64
Thomas, S., & Robitaille, R. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-04-01087.2001 · Cited by 63
“Here we show that SNAP, another NO donor (Ignarro et al., 1981; Southam and Garthwaite, 1991), produced similar effects.”
Gold, M. E., Wood, K. S., Buga, G. M., Byrns, R. E., & Ignarro, L. J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92632-6 · Cited by 62
Self-citationRole of L ‐arginine in the vascular actions and development of tolerance to nitroglycerin
Abou-Mohamed, G., Kaesemeyer, W., Caldwell, R. B., & Caldwell, R. W. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703293 · Cited by 63
“The mechanism of GTN's vasodilator action is generally agreed to involve denitration and release of NO from GTN which in turn activates smooth muscle guanylyl cyclase, causing vasorelaxation (Ignarro et al., 1981; Murad, 1986; Salvemini et al., 1992).”
BackgroundGisolf, J., Westerhof, B. E., van Dijk, N., Wesseling, K. H., Wieling, W., & Karemaker, J. M. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.04.038 · Cited by 59
Gardiner, S. M., Kemp, P. A., Bennett, T. M., Palmer, R. M. J., & Moncada, S. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb13985.x · Cited by 62
Trauner, M., Nathanson, M. H., Rydberg, S. A., Koeppel, T. A., Gartung, C., Sessa, W. C., & Boyer, J. L. (1997) · Hepatology · doi:10.1002/hep.510250522 · Cited by 60
Tseng, C.-M. L., Tabrizi‐Fard, M. A., & Fung, H. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35346-7 · Cited by 62
Worrall, N. K., Chang, K. C., Suau, G. M., et al. (1996) · Circulation Research · doi:10.1161/01.res.78.5.769 · Cited by 62
Casey, D. B., Badejo, A. M., Dhaliwal, J. S., Murthy, S. N., Hyman, A. L., Nossaman, B. D., & Kadowitz, P. J. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00543.2008 · Cited by 61
Self-citationSalom, M. G., rez, P. R., Carbonell, L. F., Conesa, E. L., Cartagena, J. N., Quesada, T., Parrilla, P., & Fenoy, F. J. (1998) · Transplantation · doi:10.1097/00007890-199805270-00006 · Cited by 60
Nitrates in different vascular beds, nitrate tolerance, and interactions with endothelial function
Bassenge, E., & Zanzinger, J. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90591-l · Cited by 61
Nitric oxide: novel therapy for osteoporosis
Wimalawansa, S. J. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560802197162 · Cited by 60
“(2008) 9(17) Discovery of NO as the endothelium-derived relaxing factor opened the door to a wide research arena [3,11,12].”
BackgroundCrane, M. S., Rossi, A. G., & Megson, I. L. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706110 · Cited by 60
“Mechanism of nitric oxide release from S-nitrosothiols.”
BackgroundInfluentialPharmacology and therapeutic role of inorganic nitrite and nitrate in vasodilatation
Bailey, J., Feelisch, M., Horowitz, J. D., Frenneaux, M. P., & Madhani, M. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.06.009 · Cited by 61
“NO-induced vasodilatation is mediated by activation of soluble guanylate cyclase (sGC), which converts guanosine triphosphate into cyclic guanosine monophosphate (cGMP), and subsequently relaxes vascular smooth muscle (Ignarro et al., 1981).”
Nitric oxide is not just blowing in the wind
Ignarro, L. J. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14540 · Cited by 60
“Even the more structurally complex organic nitrate and nitrite esters were demonstrated to elicit vascular smoothmuscle relaxation by being metabolized to NO (Ignarro et al., 1981).”
BackgroundSelf-citationNitric Oxide Mediates Penile Erection in Cats
Wang, R., Domer, F. R., Sikka, S. C., Kadowitz, P. J., & Hellstrom, W. J. G. (1994) · The Journal of Urology · doi:10.1016/s0022-5347(17)34923-6 · Cited by 57
Self-citationLeft ventricular remodeling after myocardial infarction: past, present, and future.
Tiyyagura, S. R., & Pinney, S. (2006) · PubMed · Cited by 61
Mechanism of vasodilation by molsidomine
Kukovetz, W. R., & Holzmann, S. (1985) · American Heart Journal · doi:10.1016/0002-8703(85)90669-6 · Cited by 60
Role of the Red Blood Cell in Nitric Oxide Homeostasis and Hypoxic Vasodilation
Gladwin, M. T. (2007) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-34817-9_17 · Cited by 59
Ardissino, D., Merlini, P. A., Savonitto, S., et al. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00005-3 · Cited by 59
“The vasodilating effects of nitrates are currently attributed (4,5) to stimulation of the production of cyclic guanosine monophosphate in vascular smooth muscle.”
BackgroundRegulation of Neurotransmitter Reuptake by Nitric Oxide
PÖÜN, Ş., & Kuhar, M. J. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb21816.x · Cited by 59
A Reappraisal of Nitrate Therapy
Abrams, J. (1988) · JAMA · doi:10.1001/jama.1988.03720030056035 · Cited by 60
Stewart, D. J., Holtz, J., & Bassenge, E. (1987) · Circulation · doi:10.1161/01.cir.75.4.847 · Cited by 59
Steers, W. D., Guay, A. T., Leriche, A., Gingell, C., Hargreave, T., Wright, P., Price, D., & Feldman, R. (2001) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900714 · Cited by 60
Direct inhibition of platelet function by organic nitrates via nitric oxide formation
Weber, A., Strobach, H., & Schrör, K. (1993) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(93)90134-u · Cited by 59
Visser, A. E., ABRAHAM, A., SAKYI, L. J. B., et al. (1995) · Parasite Immunology · doi:10.1111/j.1365-3024.1995.tb00971.x · Cited by 59
Fluorometric Detection of BiologicalS-Nitrosothiols
Park, J. K. J., & Kostka, P. (1997) · Analytical Biochemistry · doi:10.1006/abio.1997.2159 · Cited by 58
IOANNIDIS, I., Bätz, M., Paul, T., Korth, H., Sustmann, R., & de GROOT, H. (1996) · Biochemical Journal · doi:10.1042/bj3180789 · Cited by 57
Cachofeiro, V., & Nasjletti, A. (1991) · Hypertension · doi:10.1161/01.hyp.18.5.683 · Cited by 58
“It is known that cGMP is the intracellular mediator of vasodilator responses to sodium nitroprusside, which spontaneously liberates NO, an activator of soluble guanylate cyclase.(18) cGMP is also a mediator of vasodilatory responses to”
BackgroundNitro containing L-arginine analogs interfere with assays for nitrate and nitrite
Greenberg, S. S., Xie, J., Spitzer, J. J., Wang, J., Lancaster, J. R., Grisham, M. B., Powers, D. R., & Giles, T. D. (1995) · Life Sciences · doi:10.1016/0024-3205(95)02181-h · Cited by 58
Flaherty, J. T. (1989) · Drugs · doi:10.2165/00003495-198937040-00006 · Cited by 58
Papka, R. E., & McNeill, D. L. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90601-3 · Cited by 58
Yi, G.-B., Chen, L., Khan, M. A., & Richter-Addo, G. B. (1997) · Inorganic Chemistry · doi:10.1021/ic970282c · Cited by 55
Vascular Effects of the Red Blood Cell Storage Lesion
Roback, J. D. (2011) · Hematology · doi:10.1182/asheducation-2011.1.475 · Cited by 57
Vascular endothelial cells and dysfunctions role of melatonin
Rezzani, R. (2012) · Frontiers in Bioscience-Elite · doi:10.2741/e601 · Cited by 57
“The primary mechanism by which NO relaxes vascular smooth muscle is by increasing intracellular cyclic GMP levels, followed by activation of protein kinase G and the subsequent phosphorylation of several regulatory proteins (50, 51).”
BackgroundBrien, J. F., McLaughlin, B. E., Nakatsu, K., & Marks, G. S. (1996) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(96)68011-2 · Cited by 56
Eaton, J. W., & Qian, M. (2002) · Springer eBooks · doi:10.1007/978-1-4615-1087-1_15 · Cited by 57
Verovski, V. N., den Berge, D. V., Soete, G., Bols, B., & Storme, G. A. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.623 · Cited by 56
Metabolism of nitroglycerin by smooth muscle cells
Hill, K. E., Hunt, R. W., Jones, R., Hoover, R. L., & Burk, R. F. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90579-8 · Cited by 56
Parker, J. D., Parker, J. O., Parker, J. O., et al. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90322-r · Cited by 57
Benjamin, N., Dutton, J. A. E., & Ritter, J. M. (1991) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1991.tb12264.x · Cited by 57
Tolerance to relaxation in rat aorta: comparison of an S-nitrpsothiol with nitroglycerin
Kowaluk, E. A., Poliszczuk, R., & Fung, H. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90392-x · Cited by 57
Electrophilic nitro-fatty acids: anti-inflammatory mediators in the vascular compartment
Khoo, N. K., & Freeman, B. A. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.11.003 · Cited by 56
“Endothelial NO plays a critical role in the regulation of vascular homeostasis by inhibiting inflammatory cell function and smooth muscle proliferation [1,2].”
BackgroundRicardo, K. F. S., Shishido, S. M., de Oliveira, M. G., & Krieger, M. H. (2002) · Nitric Oxide · doi:10.1016/s1089-8603(02)00009-5 · Cited by 56
Peranovich, T. M. S., da Silva, A. M., Fries, D. M., Stern, A., & Monteiro, H. P. (1995) · Biochemical Journal · doi:10.1042/bj3050613 · Cited by 56
Dusting, G. J. (1996) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8988-9_3 · Cited by 55
Evidence for the involvement of cGMP in neural bronchodilator responses in humal trachea.
Ward, J. K., Barnes, P. J., Tadjkarimi, S., Yacoub, M. H., & Belvisi, M. G. (1995) · The Journal of Physiology · doi:10.1113/jphysiol.1995.sp020603 · Cited by 56
Inhibition of glutamate-induced cell death by sodium nitroprusside is not mediated by nitric oxide
Kiedrowski, L. (1991) · Neuropharmacology · doi:10.1016/0028-3908(91)90171-7 · Cited by 56
Slivka, A., Chuttani, R., Carr-Locke, D. L., Kobzik, L., Bredt, D. S., Loscalzo, J., & Stamler, J. S. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117527 · Cited by 55
Wang, Y. G., Rechenmacher, C. E., & Lipsius, S. L. (1998) · The Journal of General Physiology · doi:10.1085/jgp.111.1.113 · Cited by 56
Nitric Oxide in the Penis—Science and Therapeutic Implications from Erectile Dysfunction to Priapism
Burnett, A. L. “. (2006) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2006.00270.x · Cited by 55
Roediger, W. E. W. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03612.x · Cited by 55
Ikebe, N., Akaike, T., Miyamoto, Y., et al. (2000) · PubMed · Cited by 55
Short and long-acting oral nitrates for stable angina pectoris
Thadani, U., & Lipicky, R. J. (1994) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00877415 · Cited by 55
“This process requires sulfhydryl groups [34]; NO or nitrosothiols stimulate soluble guanylate cyclase to produce cyclic guanosine monophosphate [37].”
BackgroundKojda, G., Kottenberg, K., Hacker, A., & Noack, E. (1998) · Pharmaceutica Acta Helvetiae · doi:10.1016/s0031-6865(97)00044-7 · Cited by 55
Mechanisms of nitrosothiol-induced antimitogenesis in aortic smooth muscle cells
Garg, U. C., & Hassid, A. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90275-m · Cited by 53
Regiospecific Nitrosation of N-terminal-blocked Tryptophan Derivatives by N2O3 at Physiological pH
Kirsch, M., Fuchs, A., & de GROOT, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300237200 · Cited by 54
Detection of nitric oxide in exhaled air during administration of nitroglycerinin vivo
Persson, M. G., Agvald, P., & Gustafsson, L. E. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb14812.x · Cited by 55
Abdelhafez, E. M. N., Abuo‐Rahma, G. E. A., Abdel‐Aziz, M., et al. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.04.037 · Cited by 54
Nitric oxide donating compounds stimulate human colonic ion transport in vitro.
Stack, W. A., Filipowicz, B., & Hawkey, C. J. (1996) · Gut · doi:10.1136/gut.39.1.93 · Cited by 54
Eaton, J. W., & Qian, M. (2002) · Molecular and Cellular Biochemistry · doi:10.1023/a:1015988817587 · Cited by 54
“However, as mentioned earlier, nitrosothiols are suspected by some investigators [10-18] of being the transport form of NO.”
BackgroundNITRIC OXIDE IN ATHEROSCLEROSIS: VASCULAR PROTECTOR OR VILLAIN?
Dusting, G. J., Fennessy, P., Yin, Z., & Gurevich, V. A. (1998) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1998.tb02298.x · Cited by 54
Cell-mediated biotransformation of S-nitrosoglutathione
Gordge, M. P., Addis, P., Noronha-Dutra, A. A., & Hothersall, J. S. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00498-x · Cited by 54
Differential effects of low- and high-dose estrogen treatments on vascular responses in female rats
Bolego, C., Cignarella, A., Ruzza, R., Zaarour, C., Messi, E., ZANISI, M., & Puglisi, L. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00284-1 · Cited by 54
Seth, P. K., & Fung, H. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90115-d · Cited by 54
Soluble guanylate cyclase: an old therapeutic target re‐visited
Hobbs, A. J. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704779 · Cited by 54
“…of conditions such as angina and heart failure has been advocated for over a century (Brunton, 1867), although the mechanism of action of such compounds was not elucidated until the late 1970s and found to involve metabolic conversion to NO and subsequent activation of sGC (Ignarro et al., 1981).”
BackgroundCohn, J. N., McInnes, G. T., & Shepherd, A. M. M. (2011) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2011.00507.x · Cited by 55
“to be related to generation of nitric oxide gas as a consequence of their metabolic breakdown.(15) The pattern of vascular effect appears to differ, however, depending on the drug and its concentration at the vascular site of action.”
BackgroundNitroglycerin Fails to Lower Blood Pressure in Redox-Dead Cys42Ser PKG1α Knock-In Mouse
Rudyk, O., Prysyazhna, O. D., Burgoyne, J. R., & Eaton, P. (2012) · Circulation · doi:10.1161/circulationaha.112.101287 · Cited by 52
Nitric oxide releasing vascular catheters for eradicating bacterial infection
Pant, J., Goudie, M. J., Chaji, S. M., Johnson, B. W., & Handa, H. (2017) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.34065 · Cited by 53
Vanderkooi, J. M., Wright, W. W., & Erecińska, M. (1994) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(94)00073-5 · Cited by 53
Nitroglycerin and long-acting nitrates in clinical practice
Abrams, J. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90858-6 · Cited by 53
“lgnarro et al [5]”
Nitrates in the treatment of congestive heart failure
Elkayam, U. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00188-9 · Cited by 53
Nitric oxide: an endogenous gas
Quinn, A., Petros, A., & VALLENCE, P. (1995) · British Journal of Anaesthesia · doi:10.1093/bja/74.4.443 · Cited by 51
Kullo, I. J., Schwartz, R. S., Pompili, V. J., Tsutsui, M., Milstien, S., Fitzpatrick, L. A., Katušić, Z. S., & O’Brien, T. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.11.2405 · Cited by 54
Bennett, B. M., Schröder, H., Hayward, L. D., Waldman, S. A., & Murad, F. (1988) · Circulation Research · doi:10.1161/01.res.63.4.693 · Cited by 53
Schröder, H. C., Noack, E., & MULLER, R. (1985) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(85)80106-1 · Cited by 52
Heuzé-Joubert, I., Mennecier, P., Simonet, S., et al. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90744-o · Cited by 52
Tolerance with low dose intravenous nitroglycerin therapy in acute myocardial infarction
Jugdutt, B. I., & Warnica, J. W. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90482-7 · Cited by 50
Tolerance to organic nitrates: Clinical and experimental perspectives
Armstrong, P. W., & Moffat, J. A. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90857-4 · Cited by 52
Reversible activation of soluble guanylate cyclase by oxidizing agents
Wu, X.-B., Brüne, B., von Appen, F., & Ullrich, V. (1992) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(92)90139-n · Cited by 52
Prasad, K. (2004) · International Journal of Angiology · doi:10.1007/s00547-004-1060-4 · Cited by 51
Sheu, F., Zhu, W. X., & Fung, P. C. W. (2000) · Biophysical Journal · doi:10.1016/s0006-3495(00)76679-3 · Cited by 50
“There is evidence that RSNOs are potent vasodilators and inhibitors of platelet aggregation (Ignarro and Gruetter, 1980; Ignarro et al., 1981; Kelm and Schrader, 1990; Stamler et al., 1992b; Butler and Williams, 1993).”
Background
Metadata
- Authors
- Ignarro, L. J., Lippton, H., Edwards, J. C., Baricos, W. H., Hyman, A. L., Kadowitz, P. J., & Gruetter, C. A.
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 1981-09
- Volume
- 218
- Issue
- 3
- Pages
- 739-749
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W1907994445
- Cited by
- 1,633
- References
- 0
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 2 · 2023: 10 · 2022: 11 · 2021: 6 · 2020: 8 · 2019: 14 · 2018: 23 · 2017: 10 · 2016: 15 · 2015: 16 · 2014: 14 · 2013: 16 · 2012: 27
- FWCI
- 18.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pharmacology and Experimental Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- PubMed
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Phosphodiesterase function and regulation
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- vasorelaxation, organic nitrates, nitrite, sodium nitroprusside, nitric oxide, S-nitrosothiols, guanylate cyclase activation, cyclic GMP, nitroglycerin, isosorbide dinitrate, PETN, amyl nitrite, sodium nitrite, sulfhydryl groups, coronary arteries
- MeSH terms
- Animals, Biotransformation, Cats, Cattle, Coronary Vessels, Enzyme Activation, Female, Ferricyanides, Guanylate Cyclase, Hemodynamics, Male, Nitrates, Nitric Oxide, Nitrites, Nitroprusside, Nitroso Compounds, Vasodilator Agents, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review